These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 29776556)

  • 1. Sodium channel blocker challenge in Brugada syndrome: Role in risk stratification.
    Therasse D; Probst V; Gourraud JB
    Int J Cardiol; 2018 Aug; 264():100-101. PubMed ID: 29776556
    [No Abstract]   [Full Text] [Related]  

  • 2. Value of the sodium-channel blocker challenge in Brugada syndrome.
    Therasse D; Sacher F; Babuty D; Mabo P; Mansourati J; Kyndt F; Redon R; Schott JJ; Barc J; Probst V; Gourraud JB
    Int J Cardiol; 2017 Oct; 245():178-180. PubMed ID: 28784436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New risk stratification on SCN5A mutation in Brugada syndrome.
    Li X; Shang H; Xing Y
    Int J Cardiol; 2018 Nov; 271():123. PubMed ID: 30223345
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to letter from Drs. Li et al. regarding our paper in Int. J. Cardiol. 2018. Doi: 10.1016/j.ijcard.2017.09.010: SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers.
    Amin AS; Wilde AAM; Tan HL
    Int J Cardiol; 2018 Nov; 271():124. PubMed ID: 30223346
    [No Abstract]   [Full Text] [Related]  

  • 5. Ventricular arrhythmia during ajmaline challenge for the Brugada syndrome.
    Dobbels B; De Cleen D; Ector J
    Europace; 2016 Oct; 18(10):1501-1506. PubMed ID: 26941343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations.
    Hong K; Brugada J; Oliva A; Berruezo-Sanchez A; Potenza D; Pollevick GD; Guerchicoff A; Matsuo K; Burashnikov E; Dumaine R; Towbin JA; Nesterenko V; Brugada P; Antzelevitch C; Brugada R
    Circulation; 2004 Nov; 110(19):3023-7. PubMed ID: 15520322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting the sensitivity of sodium channel blocker testing in Brugada syndrome using obligate transmittance.
    Tadros R; Wilde AAM
    Int J Cardiol; 2017 Oct; 245():183-184. PubMed ID: 28709698
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance.
    Sun AY
    JACC Clin Electrophysiol; 2019 Apr; 5(4):513-515. PubMed ID: 31000107
    [No Abstract]   [Full Text] [Related]  

  • 9. Sodium-channel blocker challenge in the familial screening of Brugada syndrome: Safety and predictors of positivity.
    Therasse D; Sacher F; Petit B; Babuty D; Mabo P; Martins R; Jesel L; Maury P; Pasquie JL; Mansourati J; Dupuis JM; Kyndt F; Thollet A; Guyomarch B; Barc J; Schott JJ; Le Marec H; Redon R; Probst V; Gourraud JB
    Heart Rhythm; 2017 Oct; 14(10):1442-1448. PubMed ID: 28666944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Ajmaline and Procainamide Provocation Tests in the Diagnosis of Brugada Syndrome.
    Cheung CC; Mellor G; Deyell MW; Ensam B; Batchvarov V; Papadakis M; Roberts JD; Leather R; Sanatani S; Healey JS; Chauhan VS; Birnie DH; Champagne J; Angaran P; Klein GJ; Yee R; Simpson CS; Talajic M; Gardner M; Yeung-Lai-Wah JA; Chakrabarti S; Laksman ZW; Sharma S; Behr ER; Krahn AD
    JACC Clin Electrophysiol; 2019 Apr; 5(4):504-512. PubMed ID: 31000106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant response to ajmaline challenge in SCN5A mutation carriers: experience from a large familial study.
    Gandjbakhch E; Fressart V; Duthoit G; Marquié C; Deharo JC; Pousset F; Hebert JL; Simon F; Himbert C; Klug D; Charron P; Hidden-Lucet F
    Int J Cardiol; 2014 Mar; 172(1):256-8. PubMed ID: 24476701
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual phenotypic transmission in Brugada syndrome.
    Hermida JS; Arnalsteen-Dassonvalle E; Kubala M; Mathiron A; Traulle S; Anbazhagan K; Hermida A; Rochette J
    Arch Cardiovasc Dis; 2013; 106(6-7):366-72. PubMed ID: 23810369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia.
    Hasdemir C; Payzin S; Kocabas U; Sahin H; Yildirim N; Alp A; Aydin M; Pfeiffer R; Burashnikov E; Wu Y; Antzelevitch C
    Heart Rhythm; 2015 Jul; 12(7):1584-94. PubMed ID: 25998140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-I Paradox of Brugada Syndrome.
    Viskin S; Hochstadt A; Rosso R
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29748179
    [No Abstract]   [Full Text] [Related]  

  • 16. Should all individuals with a nondiagnostic Brugada-electrocardiogram undergo sodium-channel blocker test?
    Zorzi A; Migliore F; Marras E; Marinelli A; Baritussio A; Allocca G; Leoni L; Perazzolo Marra M; Basso C; Buja G; Thiene G; Iliceto S; Delise P; Corrado D
    Heart Rhythm; 2012 Jun; 9(6):909-16. PubMed ID: 22334153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual response to ajmaline test in Brugada syndrome patient leads to extracorporeal membrane oxygenator support.
    Ciconte G; Monasky MM; Vicedomini G; Borrelli V; Giannelli L; Pappone C
    Europace; 2019 Oct; 21(10):1574. PubMed ID: 31157372
    [No Abstract]   [Full Text] [Related]  

  • 18. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Report of Brugada Syndrome Presenting with Cardiac Arrest Triggered by Verapamil Intoxication.
    Yakut K; Erdoğan İ; Varan B; Atar İ
    Balkan Med J; 2017 Dec; 34(6):576-579. PubMed ID: 29215340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of right precordial ST-segment elevation in structural heart disease: excitation failure by current-to-load mismatch.
    Hoogendijk MG; Potse M; Linnenbank AC; Verkerk AO; den Ruijter HM; van Amersfoorth SC; Klaver EC; Beekman L; Bezzina CR; Postema PG; Tan HL; Reimer AG; van der Wal AC; Ten Harkel AD; Dalinghaus M; Vinet A; Wilde AA; de Bakker JM; Coronel R
    Heart Rhythm; 2010; 7(2):238-48. PubMed ID: 20022821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.